Recently, as many companies and institutions have gradually canceled the remote work model that persisted after the COVID-19 pandemic and encouraged employees to return to office work, Medtronic (NYSE:MDT) have also made corresponding adjustments.

According to the "Minnesota Star Tribune",Medtronic Increases Office Attendance Requirement for Hybrid Employees from Three Days to Four Days per Week.This change will be initially implemented at seven locations in the United States, including Medtronic's operational headquarters in Fridley, Minnesota.9 Month2 Medtronic spokesperson confirmed the requirement of working on-site four days a week and stated, "This decision stems from our firm belief in the critical importance of face-to-face communication for work. The collaborative energy generated through in-person interactions not only enhances our operational efficiency but also provides the support and sense of community needed for growth, enabling us to deliver life-saving technologies to patients worldwide."

In fact, since the end of the COVID-19 pandemic, many companies have been sporadically encouraging white-collar employees to return to the office more frequently. This trend significantly accelerated earlier this year after former President Trump signed an executive order requiring federal employees to return to the office five days a week, prompting numerous businesses to follow suit. For instance, e-commerce giant Amazon and financial powerhouse JPMorgan Chase have both reinstated a five-day-a-week office attendance policy. Even in Minnesota, led by Tim·Waltz (Tim Walz) The state government led by the governor also plans to have many employees work in the office at least half of the time.

Medtronic's adjustment of its office policy this time aligns with the current overall trend.In recent years, Medtronic under the leadership of its CEOGeoff Martha Under the leadership of the company's executives, multiple rounds of restructuring, early retirement plans, and layoffs have been carried out to improve the company's profitability.However, these efforts were not smooth sailing, Trump'sTariffThe policy has hindered the company's development.

Medtronic(Medtronic)PublishTheAs of2025Year4Month25Fourth Quarter and Fiscal Year Results of the DayIn China,Net Sales89.27Billion USD, compared to the same period last year85.89Billion US dollars.Quarterly Operating Profit14.36Billion USD, compared to the same period last year10.53Billion US dollars.Quarterly Net Profit Attributable to the Company10.57Billion USD, compared to the same period last year6.54Billion USD. Net Sales for the Fiscal Year335.37billion dollars, last fiscal year was323.64Billion USD. Fiscal Year Operating Profit59.55billion dollars, last fiscal year was51.44Billion USD. Net profit attributable to the company for the fiscal year46.62Billion USD, compared to the same period last year36.76Billion US dollars.At the same time,Medtronic Announces Expected Tariffs to Impact Revenue2 Hundreds of millions to3.5 billion dollars impact. Nevertheless, the company remains optimistic about the future and expects revenue growth of approximately5%。Chief Executive OfficerGeoff Martha At the time, it was stated: "As can be seen from the large amount we have been able to offset, we are highly focused on mitigation measures. You can also see from our guidance that the fundamentals of the business are strong and getting stronger."

The adjustment of Medtronic's office policy this time is not only a part of the company's operational strategy but also reflects the efforts made by medical giants to maintain competitiveness and achieve business growth in a complex and ever-changing market environment. Whether Medtronic can smoothly develop under the new office policy and market environment remains to be seen.Instrument FamilyWill continue to follow up.